Description

Buy Haemate P 500 IU Injection Imported from Germany | Uses, Price & Availability in Pakistan

Haemate P 500 IU Injection is an imported blood-clotting factor medicine containing human coagulation Factor VIII and von Willebrand Factor (VWF). It is used under specialist medical supervision to help prevent or control bleeding in people with certain inherited bleeding disorders, including Hemophilia A and von Willebrand disease (VWD).

For patients with a diagnosed bleeding disorder, having access to the correct coagulation factor concentrate can be an important part of treatment planning. Haemate P works by replacing clotting proteins that are missing or present at insufficient levels, helping the blood form a stable clot when needed.

The product is administered intravenously after reconstitution and should be used according to the individual treatment plan prepared by a hematologist or other qualified healthcare professional. The required amount depends on the patient’s condition, body weight, severity and location of bleeding, laboratory results, and response to treatment.

At ImpoMedic, we understand that patients requiring specialized coagulation products need dependable access to genuine imported medicines. We aim to provide authentic specialty medicines with careful handling, secure packaging, and delivery support across Pakistan.

If you are searching for Haemate P 500 IU Injection Price in Pakistan, checking availability, or looking for a reliable source of this imported German product, our team can assist with current stock and ordering information.

Important: Haemate P is a prescription coagulation-factor medicine. It should be used only under the supervision of a qualified healthcare professional. The dose and treatment schedule must be individualized rather than self-selected.

Product Information

* Important: Haemate P presentations can express potency in relation to both VWF and Factor VIII, and the exact labeled potency should always be confirmed from the specific vial/packaging. Official HUMATE-P documentation, which corresponds to the same VWF/FVIII concentrate family, describes separate VWF:RCo and FVIII potencies.

What is Haemate P 500 IU Injection?

Haemate P is a plasma-derived coagulation factor concentrate containing human von Willebrand Factor and Factor VIII. These proteins play important roles in normal blood clotting.

In people with Hemophilia A, Factor VIII deficiency can impair the body’s ability to form a proper clot. In von Willebrand disease, reduced or abnormal VWF can interfere with platelet adhesion and may also result in reduced Factor VIII levels.

By replacing the required clotting proteins, Haemate P can help restore hemostasis in appropriate patients.

What is Haemate P 500 IU Used For?

Depending on the patient’s diagnosis and treatment plan, Haemate P may be used for:

Hemophilia A

It can be used for the treatment and prevention of bleeding associated with Hemophilia A, according to the applicable product information.

von Willebrand Disease

Haemate P can also be used in appropriate patients with von Willebrand disease to:

• Treat spontaneous bleeding episodes.
• Treat trauma-related bleeding.
• Help prevent excessive bleeding during or after surgery when replacement therapy is appropriate.

The appropriate treatment depends on the type and severity of the bleeding disorder and the patient’s laboratory findings.

How Does Haemate P Work?

Haemate P provides Factor VIII and von Willebrand Factor, two proteins involved in the body’s normal clotting process.

Factor VIII is an important component of the coagulation cascade. VWF helps platelets attach to sites of blood-vessel injury and also carries and stabilizes Factor VIII in the bloodstream.

Replacing these proteins can help improve clot formation in patients whose natural levels are insufficient.

Why Do Doctors Prescribe Haemate P?

Doctors may prescribe Haemate P when a patient requires VWF/FVIII replacement therapy for a diagnosed bleeding disorder.

Potential clinical benefits include:

• Replacing deficient clotting factors.
• Helping control certain bleeding episodes.
• Supporting hemostasis during appropriate surgical procedures.
• Providing both VWF and Factor VIII activity in one replacement product.
• Allowing treatment to be adjusted according to laboratory monitoring and clinical response.

The treatment goal and required dose are different for every patient, so specialist supervision is essential.

How Does Haemate P 500 IU Injection Work?

Haemate P 500 IU Injection contains two important blood-clotting proteins: human Coagulation Factor VIII (FVIII) and human von Willebrand Factor (VWF).

Factor VIII is an essential part of the clotting process, while von Willebrand Factor helps platelets attach to damaged blood vessels and also helps stabilize Factor VIII in the bloodstream.

By replacing these proteins, Haemate P can help restore normal clotting activity in people who have insufficient levels of Factor VIII or VWF.

Haemate P 500 IU Dosage and Administration

There is no single fixed dose that is appropriate for every patient.

The required dose depends on factors such as:

• The underlying bleeding disorder.
• Location and severity of bleeding.
• Patient’s body weight.
• Current Factor VIII and/or VWF levels.
• Whether the medicine is being used before or after surgery.
• The patient’s response to previous treatment.
• Presence of Factor VIII inhibitors where relevant.

Haemate P is reconstituted before administration and given intravenously (IV) by a qualified healthcare professional. Laboratory monitoring may be required to guide treatment.

Do not calculate or administer a Haemate P dose yourself. The prescribing hematologist should determine the appropriate dose and treatment interval.

Haemate P for Hemophilia A

Hemophilia A occurs when the body does not have enough functional Factor VIII for normal blood clotting.

Haemate P provides human Factor VIII, which can help replace the deficient clotting activity and support the treatment or prevention of bleeding in appropriate patients with Hemophilia A.

The treatment plan is individualized according to the patient’s Factor VIII level, type and severity of bleeding, body weight, and other clinical factors.

Haemate P for von Willebrand Disease

von Willebrand disease (VWD) is a bleeding disorder associated with insufficient or abnormal von Willebrand Factor.

Because Haemate P provides both VWF and Factor VIII, it may be used in appropriate VWD patients when replacement therapy is required—for example, to treat certain bleeding episodes or to help prevent excessive bleeding around surgery.

The decision to use Haemate P depends on the patient’s specific type and severity of VWD and whether other treatments, such as desmopressin, are appropriate.

Possible Side Effects of Haemate P 500 IU

Most patients tolerate coagulation factor replacement therapy appropriately, but side effects can occur.

Possible reactions include:

• Headache.
• Dizziness.
• Nausea.
• Injection or infusion-site reactions.
• Hypersensitivity or allergic reactions.
• Fever or chills.
• Increased heart rate.
• Skin reactions such as rash or itching.

The exact frequency of adverse reactions can vary between product information and patient populations.

Serious Side Effects and When to Seek Medical Help

Seek immediate medical attention if you develop symptoms suggesting a severe allergic reaction, such as:

• Difficulty breathing.
• Swelling of the face, lips, or throat.
• Severe dizziness or a sudden drop in blood pressure.
• Widespread hives or severe rash.
• Loss of consciousness.

Patients receiving VWF/FVIII replacement may also require monitoring for thromboembolic complications, particularly when high or repeated doses are necessary.

Important Warnings and Precautions

Before receiving Haemate P 500 IU Injection, tell your healthcare professional if you:

• Have previously experienced a severe allergic reaction to Factor VIII, VWF, or similar blood-derived products.
• Have developed Factor VIII inhibitors during previous treatment.
• Have a history of blood clots or conditions associated with increased thrombosis risk.
• Are pregnant or breastfeeding.
• Are receiving other medicines or coagulation products.

Because Haemate P is manufactured from human plasma, modern manufacturing and screening procedures are used to reduce the risk of transmission of infectious agents; however, the possibility cannot be considered completely eliminated.

Monitoring During Haemate P Treatment

Your hematologist may monitor treatment using blood tests such as:

• Factor VIII activity.
• VWF activity.
• Other coagulation parameters.
• Clinical response to treatment.
• Evidence of inhibitors when clinically appropriate.

Patients receiving repeated or high doses may require additional monitoring for complications, including excessive increases in clotting-factor activity and thromboembolic events.

Haemate P 500 IU: What Patients Should Know

Haemate P 500 IU Injection is a specialized coagulation-factor medicine rather than a general-purpose injection for bleeding.

The exact presentation matters: the documented Haemate P 500 IU FVIII:C / 1200 IU VWF:RCo presentation contains 500 IU Factor VIII and 1,200 IU VWF:RCo per vial after reconstitution as specified in the product information.

For this reason, patients should always check the actual vial and packaging and follow the prescribing information supplied with their specific product.

Haemate P 500 IU Injection Price in Pakistan

The Haemate P 500 IU Injection Price in Pakistan can vary depending on import availability, supplier pricing, exchange rates, and current market conditions. Imported specialty medicines may also have limited availability at different times.

If you are looking for the latest Haemate P 500 IU price in Pakistan, contact ImpoMedic to confirm the current price and availability before placing an order.

Price Note: The current price may change according to supplier and import costs. Please confirm the latest price with our team before ordering.

Buy Haemate P 500 IU Injection Online in Pakistan

When purchasing a specialized coagulation-factor medicine such as Haemate P, product authenticity, correct storage, and reliable handling are particularly important.

ImpoMedic provides access to imported specialty medicines for patients and caregivers in Pakistan. If you have a valid prescription for Haemate P 500 IU Injection, our team can help you check availability, current pricing, and order requirements.

Before purchasing, always verify the product name, strength, batch details, expiry date, and packaging against your prescription and the medicine supplied to you.

Prescription Medicine: Haemate P should be used only under the supervision of a qualified hematologist or healthcare professional.

Why Choose ImpoMedic?

For specialty medicines, patients need more than just product availability. They need a supplier that understands the importance of authenticity, handling, packaging, and reliable communication.

At ImpoMedic, we focus on:

• Genuine imported specialty medicines.
• Careful order processing.
• Secure packaging.
• Assistance with product availability.
• Support for patients and caregivers.
• Delivery services across Pakistan.
• Transparent communication regarding pricing and availability.

Our aim is to make access to specialized medicines simpler while keeping patient safety at the center of the process.

Haemate p 500 IU injection Storage and Handling

Proper storage is particularly important for coagulation-factor products.

For Haemate P, follow the storage conditions printed on the specific manufacturer’s packaging and accompanying product information.

Important precautions include:

• Keep the unopened product stored according to the manufacturer’s specified temperature.
• Protect the medicine from inappropriate heat and direct sunlight.
• Do not freeze the product unless the official product information specifically permits it.
• Keep the vial in its original packaging until required.
• Check the expiry date before use.
• Do not use the product if the packaging or vial appears damaged.
• Reconstitution and administration should be performed according to the manufacturer’s instructions by an appropriately trained healthcare professional.

Because storage requirements can vary by market and presentation, the instructions supplied with the actual product should always take priority.

Important Safety Information

Haemate P 500 IU Injection should only be used for a diagnosed bleeding disorder and under specialist medical supervision.

Tell your doctor if you have:

• Previously experienced an allergic reaction to Factor VIII or VWF products.
• Developed Factor VIII inhibitors during previous treatment.
• A history of thrombosis or conditions that increase the risk of blood clots.
• Other medical conditions requiring regular medication.
• Pregnancy or breastfeeding.

During treatment, your healthcare provider may monitor Factor VIII activity, VWF activity, clinical response, and other relevant coagulation parameters.

Contact your healthcare professional immediately if you develop symptoms of a severe allergic reaction or symptoms that could indicate a blood clot.

Manufacturer & Company Information

Haemate P is a plasma-derived coagulation-factor medicine from CSL Behring, a global biotechnology company specializing in plasma-derived and recombinant therapies. The product contains human von Willebrand Factor (VWF) and Coagulation Factor VIII and is manufactured for the treatment of certain bleeding disorders, including Hemophilia A and von Willebrand disease.

Haemate P is manufactured by CSL Behring GmbH in Marburg, Germany, for relevant product presentations. Because manufacturing and distribution details can vary between markets, patients should always check the manufacturer, batch number, expiry date, and country of origin printed on the actual packaging supplied with their medicine.

Company Details

Important: Product packaging should always be considered the final reference for the exact manufacturer, strength, batch, expiry date, and market-specific information.

Why Choose ImpoMedic for Haemate P 500 IU Injection?

When purchasing a specialized coagulation-factor medicine such as Haemate P 500 IU Injection, authenticity and appropriate product handling matter. ImpoMedic focuses on helping patients and caregivers access genuine imported specialty medicines in Pakistan.

Why Patients Choose ImpoMedic

Genuine Imported Medicines
We focus on supplying authentic imported medicines and provide product information to help customers make informed purchasing decisions.

Specialty Medicine Support
Haemate P is not a routine medicine. Our team can assist customers in checking product availability, strength, pricing, and ordering requirements.

Secure Packaging
Specialty medicines require careful handling. Orders are packed securely to reduce the risk of damage during transportation.

Availability Confirmation
Because imported coagulation-factor products may have limited or changing availability, customers can confirm current stock before placing an order.

Nationwide Delivery in Pakistan
ImpoMedic provides delivery support for customers across Pakistan, making access to imported specialty medicines more convenient.

Transparent Product Information
We aim to provide clear information about the product, including its generic components, strength, manufacturer, therapeutic use, storage requirements, and prescription status.

Patient-Focused Support
If you are purchasing Haemate P for yourself or a family member, our support team can help with product-related and ordering queries.

Prescription Notice: Haemate P 500 IU should only be used according to the prescription and treatment plan provided by a qualified hematologist or healthcare professional.

Frequently Asked Questions (FAQs)

1. What is Haemate P 500 IU Injection used for?

Haemate P 500 IU Injection contains human Factor VIII and von Willebrand Factor (VWF). It may be prescribed for appropriate patients with Hemophilia A or von Willebrand disease to treat or prevent bleeding when factor replacement therapy is required.

2. How does Haemate P 500 IU work?

Haemate P replaces clotting proteins that are deficient or insufficient in certain bleeding disorders. Factor VIII supports the blood-clotting process, while VWF helps platelets attach to injured blood vessels and supports the stability of Factor VIII in the blood.

3. Is Haemate P used for Hemophilia A?

Yes. Haemate P can be used for Factor VIII replacement in Hemophilia A. The appropriate dose and treatment schedule depend on the patient’s Factor VIII level, bleeding episode, body weight, clinical condition, and laboratory monitoring.

4. Can Haemate P be used for von Willebrand disease?

Yes. Haemate P may be prescribed for appropriate patients with von Willebrand disease (VWD) when VWF replacement is required, including certain bleeding episodes or situations involving surgery.

5. How is Haemate P 500 IU Injection administered?

Haemate P is administered intravenously (IV) after the powder has been properly reconstituted. It should be prepared and administered by a qualified healthcare professional according to the manufacturer’s instructions and the patient’s treatment plan.

6. What is the correct Haemate p 500 IU injection dosage?

There is no universal dose for every patient. The required amount is determined by the treating specialist based on the underlying bleeding disorder, severity and location of bleeding, body weight, laboratory results, and response to treatment. Patients should never determine the dose themselves.

7. What are the possible side effects of Haemate P 500 IU injection?

Possible adverse effects can include headache, dizziness, nausea, injection-site reactions, rash, itching, fever, chills, and hypersensitivity reactions. Your healthcare provider can explain the risks relevant to your particular treatment.

8. Can Haemate p 500 IU injection cause an allergic reaction?

Yes. Although uncommon, hypersensitivity reactions can occur. Seek urgent medical attention for symptoms such as difficulty breathing, swelling of the face or throat, widespread hives, severe dizziness, or loss of consciousness.

9. Does Haemate p 500 IU injection increase the risk of blood clots?

Treatment with VWF-containing factor concentrates can require monitoring for thromboembolic complications, particularly in patients receiving repeated or high doses or those with additional risk factors. Your hematologist will determine the appropriate treatment and monitoring plan.

10. What is the Haemate P 500 IU Injection Price in Pakistan?

The Haemate P 500 IU Injection Price in Pakistan can vary due to its status as an imported specialty medicine. Supplier pricing, import costs, exchange rates, and availability can affect the current price. Contact ImpoMedic for the latest price and stock information.

11. Where can I Buy Haemate P 500 IU Injection Online in Pakistan?

If you have a valid prescription, you can contact ImpoMedic to check the availability and current price of Haemate P 500 IU Injection. Because this is a specialized coagulation factor medicine, it should only be purchased and used under the advice of a healthcare professional.

12. How should Haemate P 500 IU injection be stored?

Haemate P should be stored according to the specific manufacturer’s storage instructions printed on the product packaging. Protect the medicine from inappropriate temperatures and direct sunlight, and do not use it if the vial or packaging is damaged or the product has expired.

13. Is Haemate P 500 IU imported from Germany?

The Haemate P product is associated with CSL Behring’s plasma-derived coagulation-factor product range and has been manufactured in Germany for certain presentations/markets. Because manufacturing and distribution details can vary by market, check the actual packaging and batch information of the product being supplied.

14. Can Haemate p 500 iu injection be used without a prescription?

No. Haemate P is a specialized prescription coagulation-factor medicine and should be used only after assessment by an appropriate healthcare professional. The dose and frequency should be determined according to the patient’s individual condition.